European Medical Device Company Signs Agreement to Use OmniComm’s TrialMaster


Applied Clinical Trials

OmniComm Systems, Inc., a global provider of clniical data management technology, announced that a major European medical device company specializing in ophthalmology has signed a three-year agreement to use  it's TrialMaster EDC. The medical device company will use TrialMaster to build and manage multiple clinical studies.

Read the full release here.



Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.